Larimar Therapeutics, Inc. SEC filings LRMR
Larimar Therapeutics, Inc. has 696 filings in SEC EDGAR's recent list, going back to Aug 28, 2006. Its latest annual report, Form ARS, was filed on Apr 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 4, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 29, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Apr 20, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Mar 19, 2026 | Dec 31, 2025 |
| ARS | Annual report to shareholders | Apr 11, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Mar 24, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | Apr 29, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 14, 2024 | Dec 31, 2023 |
| ARS | Annual report to shareholders | Apr 11, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 14, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 25, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Mar 4, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Mar 5, 2020 | Dec 31, 2019 |
| 10-K | Annual report | Mar 14, 2019 | Dec 31, 2018 |
| 10-K | Annual report | Mar 9, 2018 | Dec 31, 2017 |
| 10-K | Annual report | Mar 10, 2017 | Dec 31, 2016 |
| 10-K/A | Amended annual report | Apr 29, 2016 | Dec 31, 2015 |
| 10-K | Annual report | Mar 15, 2016 | Dec 31, 2015 |
| 10-K | Annual report | Mar 25, 2015 | Dec 31, 2014 |
Showing 17 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LRMR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Bala Cynwyd, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1374690
- Former names
- ZAFGEN, INC. (until May 19, 2020); ZAFGEN INC (until Nov 3, 2008)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.